Gyre TherapeuticsGYRE
13F holders, Q1 2025 (March 31)45holders +5
8new positions
3sold out
$7.72avg. 13F price*
At the end of Q1 2025, 45 institutions reported holding Gyre Therapeutics Inc. (GYRE) in their 13F filings, up 5 from Q4 2024. 8 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($8.5M), BlackRock, Inc. ($4.2M) and Geode Capital Management, LLC ($2.4M).
- Company
- Gyre Therapeutics Inc.
- CUSIP
- 403783103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $341K |
| Exits | 3 | $45K |
All 13F filers, Q4 2024 → Q1 2025: 880,289 shares bought and 58,145 shares sold, net +822,144 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 45 holders
| Vanguard Group Inc. | 0.00% | Add +240.0% | 1,096,488 | $8.5M |
| BlackRock, Inc. | 0.00% | Add +2.9% | 547,210 | $4.2M |
| Geode Capital Management, LLC | 0.00% | Add +2.7% | 312,319 | $2.4M |
| State Street Corp. | 0.00% | Add +1.7% | 128,773 | $994K |
| SBI Securities Co., Ltd. | 0.03% | Add +22.1% | 123,629 | $954K |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -2.8% | 111,416 | $860K |
| Northern Trust Corp. | 0.00% | Add +4.5% | 108,010 | $834K |
| UBS Group AG | 0.00% | Reduce -57.4% | 24,306 | $188K |
| American Century Companies Inc. | 0.00% | New | 23,825 | $184K |
| Susquehanna International Group, LLP | 0.00% | New | 16,931 | $131K |
| Bank of New York Mellon Corp | 0.00% | Add +18.7% | 16,492 | $127K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -38.8% | 16,147 | $125K |
| Morgan Stanley | 0.00% | Reduce -8.0% | 14,030 | $108K |
| Advantage Alpha Capital Partners LP | 0.03% | Add +54.0% | 13,663 | $105K |
| Rhumbline Advisers | 0.00% | Add +6.8% | 11,141 | $86K |
| Barclays PLC | 0.00% | Reduce -19.8% | 8,451 | $65K |
| Bank of America Corp. | 0.00% | Reduce -29.7% | 4,875 | $38K |
| Citigroup Inc. | 0.00% | Reduce -10.1% | 4,853 | $37K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +3.9% | 4,169 | $32K |
| Wells Fargo & Company | 0.00% | Add +2.3% | 4,108 | $32K |
| JPMorgan Chase & Co. | 0.00% | Add +7.1% | 3,500 | $27K |
| Corebridge Financial, Inc. | 0.00% | Reduce -1.5% | 3,417 | $26K |
| New York State Common Retirement Fund | 0.00% | No change | 2,700 | $21K |
| Police & Firemen's Retirement System of New Jersey | 0.00% | New | 2,097 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +23.1% | 1,049 | $8K |
| Lazard Asset Management LLC | 0.00% | New | 833 | $6K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 683 | $5K |
| Legal & General Group Plc | 0.00% | No change | 603 | $5K |
| Activest Wealth Management | 0.00% | No change | 533 | $4K |
| California State Teachers Retirement System | 0.00% | No change | 505 | $4K |
| BNP Paribas Financial Markets | 0.00% | Reduce -64.5% | 495 | $4K |
| Group One Trading LLC | 0.00% | New | 485 | $4K |
| Royal Bank of Canada | 0.00% | Reduce -51.6% | 392 | $3K |
| FMR LLC | 0.00% | Reduce -70.1% | 376 | $3K |
| Amalgamated Bank | 0.00% | No change | 241 | $2K |
| GAMMA Investing LLC | 0.00% | Add +1866.7% | 236 | $2K |
| Cwm, LLC | 0.00% | Add +813.3% | 137 | $1K |
| Sterling Capital Management LLC | 0.00% | Reduce -50.9% | 106 | $818 |
| Aster Capital Management (DIFC) Ltd | 0.00% | New | 59 | $684 |
| Nisa Investment Advisors, LLC | 0.00% | Reduce -27.4% | 61 | $471 |
| US Bancorp \de | 0.00% | New | 17 | $131 |
| Osaic Holdings, Inc. | 0.00% | Reduce -73.2% | 11 | $85 |
| True Wealth Design, LLC | 0.00% | New | 6 | $47 |
| IFP Advisors, Inc | 0.00% | No change | 2 | $15 |
| Covestor Ltd | 0.00% | No change | 7 | $0 |
"% of holder's portfolio" is GYRE's weight in each manager's 13F, not the share of Gyre Therapeutics Inc. the manager owns.